A 23-year-old man with recurrent thymus cancer was diagnosed with brain metastases and underwent surgical resection. Prior to the surgery, he had experienced pain due to invasive recurrent tumors in the left thoracic cavity. The pain was managed using 640 mg of oxycodone sustained-release tablets, 240 mg of morphine sustained-release tablets, and 320 mg of ketamine liquid, administered daily. These medications were continued until the morning of surgery; the operation was performed under general anesthesia. Post-operatively, he was initially administered 80 mg of short-acting oxycodone powder through the nasogastric tube at the onset of pain, while the regular analgesic medication was suspended. From 24-hours post-surgery onward, he received 200 mg of short-acting oxycodone and 80 mg of ketamine through the nasogastric tube at fixed intervals of 6 hours. His regular oral medications were resumed 48 hours after surgery. Our experience suggests that if the postoperative fasting period is short, optimal postoperative cancer pain management can be achieved by administering short-acting oxycodone powder and ketamine through a nasogastric tube.
View full abstract